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Abstract
Background: High prevalence of depression has been reported in otorhinolaryngologic patients (ORL). However,
studies using a semi-structured interview to determine the prevalence of depression in ORL are lacking. Therefore
the present study sought to determine the depression prevalence in ORL applying a semi-structured diagnostic
interview and to further characterize the pathopsychological and demographic characteristics of depression in
these patients.
Methods: One-hundred inpatients of the otorhinolaryngologic department of a German university hospital
participated voluntarily (age M = 38.8 years, SD = 13.9; 38.0% female). Depression was assessed using a clinical
interview in which the International Diagnostic Checklist for depression (IDCL) was applied. Patients completed the
Brief Symptom Inventory (BSI) which constitutes three composite scores and nine symptom scales and the Beck
Depression Inventory (BDI). Multivariate analyses of variance, correlations and effect sizes were conducted.
Results: A prevalence of depression of 21.0% was determined, 38.0% of the depressed patients were female.
Depressed patients showed higher scores on the BSI-scales “interpersonal sensitivity”, “depression”, “anxiety”,
“phobic anxiety” and “psychoticism” with medium effect sizes.
Conclusions: High prevalence of depression was found which is in accordance with results of prior studies.
Depressed patients showed higher psychological distress as compared to non-depressed patients. The results call
for carrying on in engaging in depression research and routine depression screening in ORL.
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Background
Depressive disorders are among the most prevalent
mental disorders of our times [1,2], coinciding with
increased symptom burden, functional impairment, and
immense socio-economical costs. Prevalence was found
to be especially high in populations of patients with
physical diseases [3-6]. Furthermore, depression may
affect the course of comorbid physical illnesses and wor-
sen their outcomes [5]. In general, depression reduces
functional, emotional, cognitive and physical capacities
needed to recover from coexisting somatic diseases.
Concerning depression in otorhinolaryngologic (ORL)
diseases, prior studies mostly report high prevalences.
Values range from 10% to 26% [7-11] indicating that
patients with ORL are at high risk for depression. This is
not surprising considering that characteristics of ORL
diseases may entail severe consequences on subjective
functioning and everyday quality of life [12].
However it is important to note, that in most published
studies only self-report instruments were used to assess
depression, e.g., the Hospital Anxiety and Depression
Scale [HADS; 7,8]. Those studies that applied a higher
diagnostic standard, e.g. the use of diagnostic interviews,
mostly referring to head and neck cancer, reported highly
divergent prevalence rates depending for example on the
subsample of ORL patients [13-15]. In some studies, no
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standardized instrument was applied at all [9,10], or no
information about how depressive diagnoses were deter-
mined were reported [11]. This is critical since validity
and reliability of epidemiological studies depend largely
on the quality of the instrument applied to collect diag-
nostic information.
The international accepted “gold standard” for diagnos-
ing mental disorders like depression is a semi-structured
diagnostic interview conducted by trained personnel.
Self-report instruments are often used instead for eco-
nomical reasons. However, to allow for reliable and
sound conclusions in studies on the prevalence of depres-
sion, applying the diagnostic gold standard is strongly
demanded. Nevertheless, studies using a semi-structured
interview to determine the prevalence of depression in
ORL are lacking.
Therefore, the present study had two major aims: (a) to
determine the prevalence of depression in consecutive
ORL inpatients applying a semi-structured diagnostic
interview; (b) to compare the pathopsychological and
demographic characteristics of depressed and non-
depressed ORL inpatients in order to gain further insight
into the characteristics of patients suffering from depres-
sive disorders in this population.
Methods
Design
This was a cross-sectional study with consecutive inpati-
ents of the department for otorhinolaryngology of a
German university hospital. Prevalence of depressive
disorders was determined. Depressive status served than
as independent variable while measures of mental symp-
tom burden (Somatisation, Obsessive-Compulsive, Inter-
personal Sensitivity, Depression, Anxiety, Hostility, Phobic
Anxiety, Paranoid Ideation, Psychoticism) were assessed as
dependent variables.
Sample
One-hundred and two consecutive inpatients of the
department for otorhinolaryngology of a German univer-
sity hospital participated voluntarily. Two participants
suffering from chronic diseases for more than 30 years
were excluded from analyses because this time period
exceeded the mean duration of disease in the sample by
much more than two standard deviations. Overall mean
age of the remaining 100 patients was 38.8 years (SD =
13.9) and 38.0% were female. See table 1 for sample
details. Participants took part voluntarily without pay-
ment and signed an informed consent prior to testing.
General inclusion criteria were German language skills
and the ability to concentrate for at least 1 hour. Test
administration was conducted by trained personnel. The
study was approved by the local ethics committee of the
Medical Faculty of the RWTH Aachen University (EK
172/05) and performed according to the Declaration of
Helsinki [16].
Procedures
Test sessions took place at admission and started with the
conduction of a clinical interview in which the Interna-
tional Diagnostic Checklist for depression [IDCL; 17] was
conducted. Afterwards, participants completed a demo-
graphic data sheet, and filled in further questionnaires.
Measures
Clinical Interview
Depression was assessed in all participants using a clini-
cal interview in which the International Diagnostic
Checklist for depression [IDCL; 17] was employed to
verify the diagnosis. The IDCL is a checklist that can be
used to make a careful evaluation of the symptoms and
classification criteria, and thus help to arrive at precise
diagnoses according to the 10th edition of the Interna-
tional Classification of Diseases (ICD-10) criteria for a
depressive episode [18]. Persons who conducted the clini-
cal interview were either psychologists or medical stu-
dents in their last year with a major in psychiatry. All
interviewers received one week training in completing
this interview consisting of three steps: First, the inter-
view guidelines were presented and the trainee observed
a couple of interviews conducted by the principal author.
Second, the trainee did role-play interviews with the
principal author as “participant”. Third, the trainee con-
ducted interviews with real participants supervised by the
principal author. If the trainee’s diagnoses were in accor-
dance with the trainer’s, then the trainee was eligible as
an interviewer in the present study.
Brief Symptom Inventory (BSI)
The Brief Symptom Inventory is a short form of the Symp-
tom Checklist 90-R [SCL-90-R; 19] and contains 53 items
that are Likert-scaled, referring to the previous week, with
a range from 0 (“not at all”) to 4 (“very much”). The
instrument provides information on overall psychological
distress. Furthermore, the 53 items of the inventory consti-
tute three composite scores and nine symptom scales
(Somatisation, Obsessive-Compulsive, Interpersonal Sensi-
tivity, Depression, Anxiety, Hostility, Phobic Anxiety, Para-
noid Ideation, Psychoticism) allowing the calculation of
psychopathological profiles. The three composite scores
reflect the complete answer pattern of the respondent: the
“global severity index” (GSI) measures the overall mental
symptom burden, the “positive symptom distress index”
(PSDI) measures symptom intensity, and the “positive
symptom total” (PST) reflects the total number of the
respondent’s symptoms. The raw scale and composite
scores are transformed to standardized T-scores with a
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Table 1 Detailed sample description according to ICD-10; multiple diagnoses possible
N age (SD) % female duration of diseasea
(SD)
duration of staya
(SD)
Impairment ADLb
(SD)
Impairment QoLc
(SD)
BDI
sum
whole sample 100 38.8 (13.9) 38.0 151.8 (401.4) 8.3 (4.4) 1.9 (1.5) 1.8 (1.3) 6.7 (7.7)
diseases of external ear (H60-H62) 2 47.5 (3.5) 33.3 3.5 (0.7) 5.5 (0.7) 1.5 (2.1) 1.0 (1.4) 4.0 (1.4)
diseases of middle ear & mastoid (H65-H75) 1 30.0 (–) 75.0 4.0 (–) 4.0 (–) 0.0 (–) 0.0 (–) 5.0 (–)
diseases of inner ear (H80-H83) 2 42.0 (7.1) 57.1 12.0 (1.4) 10.5 (7.1) 2.5 (2.1) 3.0 (1.4) 7.0 (7.1)
hearing loss (H90-H91) 11 44.7 (13.2) 63.6 87.6 (241.0) 10.3 (5.3) 2.8 (1.3) 2.3 (1.3) 8.6 (7.9)
diseases of nose and paranasal sinuses (J01, J32, J34) 16 44.1 (17.8) 18.8 222.2 (626.4) 8.6 (5.1) 2.5 (1.4) 1.7 (1.3) 5.2 (4.3)
diseases of mouth, throat & pharynx (J03, J35-J38, K07,
K11-K13)
37 34.0 (13.5) 40.5 131.3 (305.2) 8.1 (3.7) 1.3 (1.5) 1.7 (1.5) 7.9 (9.2)
a in days; b ADL: Activities of Daily Living; c QoL: Quality of Life
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mean of 50 and a standard deviation (SD) of 10. T-scores
> 60 reflect heightened mental burden [20].
Beck Depression Inventory (BDI)
The BDI [21] contains 21 items. Each item consists of
four self-referring statements (e.g. “I am sad”). Item
scores range from 0 to 3 and participants are supposed
to choose one or more statements per item that repre-
sents best their mental state during the last week.
A total score > 10 indicates mild to moderate depres-
sion and a total score > 18 moderate to severe depres-
sion. The BDI has not been validated in ORL inpatients
so far, so that all conclusions based on the BDI in this
study should be handled with care.
Further materials
All participants completed a demographic data sheet.
Furthermore, the level of impairment in activities of
daily living (ADL) and in quality of life (QoL) was
inquired by a 5-point Likert-scale (0 = no impairment,
1 = little, 2 = moderate, 3 = strong, 4 = very strong).
Clinical data were taken from medical records. Data
were acquired within the scope of a comprehensive
research project, so that participants filled in further
questionnaires that are reported elsewhere [22].
Data analysis
The number of depressed and non-depressed ORL
patients according to IDCL was determined. Mean age
and standard deviations and number of male and female
participants in both groups were calculated.
A mulitivariate analysis of variance (MANOVA) with
“group” (depressed vs. non-depressed ORL patients) as
between-subjects-factor was conducted. Prior to MAN-
OVA, homogeneity of error variances was tested with
the Mauchly test for sphericity. Homogeneity of error
variances is important in order to interpret the results
of MANOVA validly. Therefore, in case of significant
results of the Mauchly test and thus violation of homo-
geneity of error variances, a Greenhouse-Geisser-correc-
tion was conducted. Effect sizes according to Hedges
and Olkin [23] were calculated. Effect sizes amend
significance tests reasonably since they allow for an esti-
mation of the clinical relevance of empirical differences
which is less sensitive to sample size than significance
tests (e.g., t-tests). Cohen [24] recommended to inter-
pret an effect size d of .20<d ≤.50 as small, an effect size
of .50<d ≤.80 as medium and an effect size of d ≥.80 as
large. Following the recommendations of Dunlap [25] in
the present study effect sizes were calculated for inde-
pendent variables instead of dependent variables because
effect sizes for dependent variables often overestimate
the actual size of effect.
Bivariate correlation analyses were performed to
further characterize those patients who were assigned a
depressive disorder. Classificatory (IDCL) as well as
dimensional (BDI) information about the depressive sta-
tus of the participants were correlated with age, gender,
marital status, levels of impairment in ADL and in QoL,
duration of disease, and duration of stay in hospital. All
analyses were performed using SPSS 17 for Windows.
Results
Prevalence of depression
Considering the remaining sample (N = 100), the semi-
structured interview based on the IDCL-checklist for
depression revealed that 21 participants suffered from a
depressive disorder, which corresponds to a prevalence
rate of 21.0%. The mean score of BDI was 14.2 (SD =
12.2) in the depressed and 4.8 (SD = 4.2) in the non-
depressed group. In fourteen patients (14%) a single
depressive episode was found, 5 patients (5%) exhibited a
recurrent depressive disorder. Nearly forty-eight percent
(47.6%) of those patients with any depressive disorder
were women (table 2). The mean age of patients with
depression was 39.4 years (SD = 11.7) and the mean age
of those without depression was 38.6 years (SD = 14.5;
see table 2 for details).
Psychopathological and demographic characteristics of
depressed vs. non-depressed ORL patients
The Mauchly test for sphericity revealed inhomogeneity
of error variances (Mauchly-W = .013; p < .001). Thus,
a Greenhouse-Geisser correction was performed prior to
MANOVA. Depressed patients had higher scores than
non-depressed patients on all scales (Somatisation,
Obsessive-Compulsive, Interpersonal Sensitivity, Depres-
sion, Anxiety, Hostility, Phobic Anxiety, Paranoid Idea-
tion, Psychoticism) and all three composite scores GSI,
PSDI and PST. However, the corresponding main effect
“group” was not significant (F = .85; df = 1; p = .60).
Univariate tests of between subjects effects showed sig-
nificant differences between depressed and non-depressed
patients on the scales “depression” (F = 4.53; df = 1; p =
.04) and “anxiety” (F = 4.84; df = 1; p = .03) and for the
global score PSDI (F = 4.38; df = 1; p = .04). Analyses of
effect sizes showed relevant effect sizes between depressed
and non-depressed patients of medium size for “interper-
sonal sensitivity”, “depression”, “anxiety”, “phobic anxiety”,
“psychoticism” and the PSDI (see table 3). Most mean
scores in both groups were within the range of normal
mental symptom burden (T-value = 50 +/- 10). Only the
mean score on the composite score PST in the depressed
group was greater than a T-value of 60.
Bivariate correlation analyses between classificatory
(IDCL) as well as dimensional (BDI) information about
the depressive status of the participants, age, gender,
marital status, levels of impairment in ADL and QoL,
duration of disease, and duration of stay in hospital
were performed. Gender correlated significantly with
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dimensional information about the depression status
(BDI) of participants (r = .25; p = .013) which persisted
when controlling for age: depressed patients were
slightly more likely to be male. No further significant
correlations were found.
Discussion
The calculated overall prevalence of depression was
21.0%. Gender was significantly correlated with classifi-
catory information about the patients’ affective status.
This is largely in accordance with published data on the
prevalence of depression in this patient collective [7-10].
The fact that slightly more male than female patients
exhibited depressive symptoms might be explainable by
the higher base rate of male patients (62%) in the study
sample. Generally, the present study confirms results of
previous investigations. However, a more reliable techni-
que for determination of the diagnostic information was
applied here (semi-structured interview) as compared to
most other published studies on the prevalence of
depression in ORL, so that we further substantiated pre-
vious findings. Above, analyses were conducted with
data of an unselected sample of consecutive ORL inpati-
ents. Therefore, the prevalence rate reported here
reflects more directly the situation that clinicians
encounter in their routine clinical practice than most
previous studies did.
Depressed patients reported to suffer more from
symptoms referring to anxiety, depression, interpersonal
sensitivity, psychoticism, and phobic anxiety than non-
depressed patients. Differences were moderate in terms
of effect sizes. However, total symptom burden on most
BSI-scales was only moderate in both groups. Neverthe-
less, all mean scores coincided with a huge standard
deviation indicating that patients within both groups dif-
fered largely in terms of symptom burden.
The present study largely replicated the picture of
depression that is known from a multiplicity of studies
on this disease in other samples: It is a well known fact
that depression often co-occurs with anxiety and obses-
sive-compulsive or phobic disorders, respectively [26-28].
The prevalence rate of depression found in the present
study is largely consistent with prevalence rates of
depression reported in other medical illnesses, e.g., car-
diac diseases (17-27%) [29], cerebrovascular diseases
(14-19%) [30], obesity (20-30%) [31], cancer (22-29%)
[32] or HIV/AIDS (5-20%) [33]. Simultaneously, it is
considerably higher than the prevalence found in the
general population (10.3%) [2]. Evans [5] assembled stu-
dies that indicate a bi-directional relation between
depression and comorbid medical illnesses: severe medi-
cal illness is an accepted risk factor for developing a
Table 2 Prevalence rates according to ICD-10, divided by gender and diagnosis
all patients female male
Diagnosis frequency percentage frequency percentage frequency percentage
no depressive disorder 79 79.0 28 35.4 51 64.6
any depressive disorder 21 21.0 10 47.6 11 52.4
F31.3: Bipolar affective disorder, current episode mild or moderate
depression
1 1.0 1 100.0 0 0.0
F31.4: Bipolar affective disorder, current episode severe depression 1 1.0 1 100.0 0 0.0
F32.0: Mild depressive episode 8 8.0 2 25.0 6 75.0
F32.1: Moderate depressive episode 4 4.0 1 25.0 3 75.0
F32.2: Severe depressive episode without psychotic symptoms 1 1.0 0 0.0 1 100.0
F32.4: depressive episode, in partial remission 1 1.0 0 0.0 1 100.0
F33.1: Recurrent depressive disorder, current episode moderate 2 2.0 2 100.0 0 0.0
F33.2: Recurrent depressive disorder, current episode severe without
psychotic symptoms
3 3.0 3 100.0 0 0.0
total 100 100 38 38.0 62 62.0
Table 3 effect sizes between depressed and non-
depressed patients for all BSI scores
BSI score nondepressed depressed d SE
mean n SD mean n SD
somatisation 54.1 72 11.6 58.1 19 11.7 -0.34 0.26
obsessive-compulsive 47.6 73 10.9 53.2 19 15.6 -0.46 0.26
interpersonal sensitivity 47.3 74 9.6 54.6 19 15.2 -0.66 0.26
depression 48.2 74 8.6 54.9 19 13.8 -0.68 0.26
anxiety 50.1 74 10.9 58.1 18 13.9 -0.69 0.27
hostility 49.3 74 10.2 52.3 18 11.9 -0.28 0.26
phobic anxiety 49.9 74 9.3 55.5 19 9.6 -0.59 0.26
paranoid ideation 50.3 73 10.4 54.8 19 13.1 -0.40 0.26
psychoticism 49.4 72 9.7 56.5 19 13.1 -0.67 0.26
GSI 49.4 68 12.5 54.8 17 17.8 -0.39 0.27
PSDI 54.8 65 12.2 61.7 16 10.2 -0.58 0.28
PST 48.0 68 13.1 53.8 17 18.6 -0.40 0.27
Note: d = effect size, bias corrected according to Hedges & Olkin (1985); SE =
standard error of effect size estimate.
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depressive disorder. However, at the same time, it is
under debate whether depression might be a causal fac-
tor itself in the development and course of medical ill-
nesses, e.g., in cardiac diseases [34]. In this light, the
relatively high prevalence rate of depression found in
the present study might be interpreted as further evi-
dence for a strong link between depression and medical
illnesses of ORL in particular. Thus, one could assume
that depression might impair treatment and outcome of
otolaryngologic diseases like the data of Bhattacharyya &
Wasan suggest [7]. Still, further research is needed, and
especially longitudinally designed studies are required to
gain further insight into the complex relation of depres-
sion and physical disease.
In general, the conduction of a full semi-structured
diagnostic interview to assess mood in ORL-patients
would be desirable. However, since this technique is
laborious and time-consuming for both, the patient and
the investigator, it is not likely that it will become routine
diagnostic practice in ORL clinics. Still, given the general
impact of depression in patients with various physical
diseases [34,35] a routine screening for depression with
more economical instruments is highly demanded.
Therefore, future studies should engage in expanding our
body of knowledge about the screening performance
(sensitivity, specificity) of existing self-report instruments
for depression (e.g., BDI) in this patient group. A new
instrument that shows promising psychometric quality in
both patients with physical and mental illnesses is the
Rasch-based Depression Screening (DESC), which was
developed on the basis of data from patients with mental,
cardiologic, and otorhinolaryngologic diseases [36].
A limitation of the present study is that no detailed
data on those patients who declined participation is avail-
able. Patients were approached at admission if their treat-
ing physicians considered them eligible and most
(approximately > 80%) agreed to participate. Neverthe-
less, a potential bias of over- or underreporting of depres-
sion can not be ruled out. Overreporting would occur if
those persons with more severe symptoms of depression
would have been more likely to participate - e.g., because
they felt that study aims were important for people in
their present situation. Underreporting would have
occurred if those persons with more severe depression
would have been more likely to decline participation - e.
g., because symptom burden was too high. Both direc-
tions of bias may be present in most studies of this kind
and have to be kept in mind when interpreting the cur-
rent results.
Another limitation is that although published research
suggests that especially diagnoses like head and neck
cancer might be related to elevated depression [14,32],
limited sample size made it impossible to report reliable
prevalence rates for ORL subsamples with different
diagnoses so that we decided to report prevalence data
only divided by gender.
Conclusion
The results of our study call for carrying on in engaging in
research about depression in ORL inpatients and further
intensifying collaborative health care in a multidisciplinary
setting to foster optimal outcome and treatment of both,
the physical and psychic disorder.
List of abbreviations used
ADL: activities of daily living; BDI: Beck Depression Inventory; BSI: Brief
Symptom Inventory; DESC: Rasch-based Depression Screening; GSI: global
severity index; HADS: Hospital Anxiety and Depression Scale; ICD-10:
International Classification of Diseases 10th Revision; IDCL: International
Diagnostic Checklist for depression; MANOVA: analysis of variance for
repeated measures; ORL: otorhinolaryngology; PSDI: positive symptom
distress index; PST: positive symptom total; QoL: quality of life; SCL-90-R:
Symptom Checklist 90-R; SD: standard deviation
Acknowledgements and funding
This research project was supported by the START-program of the Faculty of
Medicine, RWTH Aachen and the German Research Foundation (DFG,
WI3210/2-1).
Author details
1Institute of Medical Psychology and Medical Sociology, University Hospital
of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany. 2Dept. of
Psychiatry and Psychotherapy, LWL-University-Clinic, Ruhr-University Bochum,
Alexandrinenstr. 1-3, 44791 Bochum, Germany. 3Institute of Psychology,
University of Education Freiburg, Kartäuserstr. 61b, 79117 Freiburg, Germany.
4Clinic for Otorhinolaryngology, University Hospital of RWTH Aachen,
Pauwelsstraße 30, 52074 Aachen, Germany.
Authors’ contributions
TF contributed to conception and design of the study, conducted the
statistical analysis and wrote the manuscript. CN participated in the analysis
and interpretation of the data. MW participated in the design of the study
and the statistical analysis. MW and TV participated in the design of the
study and coordinated the data acquisition. SG has been involved in
drafting and revising the manuscript, and coordinated the study and data
acquisition. MB contributed to the analysis and interpretation of the data. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 December 2010 Accepted: 31 August 2011
Published: 31 August 2011
References
1. Waraich P, Goldner EM, Somers JM, Hsu L: Prevalence and incidence
studies of mood disorders: a systematic review of the literature. Can J
Psychiatry 2004, 49:124-138.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S,
Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R
psychiatric disorders in the United States. Results from the National
Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
3. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R,
Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J,
Paty DW: Depression and multiple sclerosis. Neurology 1996, 46:628-632.
4. Verdelho A, Henon H, Lebert F, Pasquier F, Leys D: Depressive symptoms
after stroke and relationship with dementia: A three-year follow-up
study. Neurology 2004, 62:905-911.
5. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR,
Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-
Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL,
Forkmann et al. BMC Ear, Nose and Throat Disorders 2011, 11:7
http://www.biomedcentral.com/1472-6815/11/7
Page 6 of 7
Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP,
Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH,
Musselman D, et al: Mood disorders in the medically ill: scientific review
and recommendations. Biol Psychiatry 2005, 58:175-189.
6. Bankier B, Januzzi JL, Littman AB: The high prevalence of multiple
psychiatric disorders in stable outpatients with coronary heart disease.
Psychosom Med 2004, 66:645-650.
7. Bhattacharyya N, Wasan A: Do anxiety and depression confound
symptom reporting and diagnostic accuracy in chronic rhinosinusitis?
Ann Otol Rhinol Laryngol 2008, 117:18-23.
8. Wasan A, Fernandez E, Jamison RN, Bhattacharyya N: Association of
anxiety and depression with reported disease severity in patients
undergoing evaluation for chronic rhinosinusitis. Ann Otol Rhinol Laryngol
2007, 116:491-497.
9. Mace J, Michael YL, Carlson NE, Litvack JR, Smith TL: Effects of depression
on quality of life improvement after endoscopic sinus surgery.
Laryngoscope 2008, 118:528-534.
10. Brandsted R, Sindwani R: Impact of depression on disease-specific
symptoms and quality of life in patients with chronic rhinosinusitis. Am J
Rhinol 2007, 21:50-54.
11. Chandra RK, Epstein VA, Fishman AJ: Prevalence of depression and
antidepressant use in an otolaryngology patient population. Otolaryngol
Head Neck Surg 2009, 141:136-138.
12. Hellgren J, Balder B, Palmqvist M, Löwhagen O, Tunsäter A, Karlsson G,
Torén K: Quality of life in non-infectious rhinitis and asthma. Rhinology
2004, 42:183-188.
13. Bronheim H, Strain JJ, Biller HF: Psychiatric aspects of head and neck
surgery. Part I: New surgical techniques and psychiatric consequences.
Gen Hosp Psychiatry 1991, 13:165-176.
14. Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H,
Uchitomi Y: Prevalence, predictive factors, and screening for psychologic
distress in patients with newly diagnosed head and neck cancer. Cancer
2000, 88:2817-2823.
15. Singer S, Herrmann E, Welzel C, Klemm E, Heim M, Schwarz R: Comorbid
mental disorders in laryngectomees. Onkologie 2005, 28:631-636.
16. World Medical Association: Proposed revision of the Declaration of
Helsinki. Bull Med Ethics 1999, 150:18-22.
17. Hiller W, Zaudiga M, Mombour W: ICD International Diagnostic Checklists for
ICD-10 and DSM-IV Göttingen: Hogrefe & Huber Pub; 1999.
18. World Health Organization: The ICD-10 classification of mental and
behavioral disorders: clinical descriptions and diagnostic guidelines Geneva:
World Health Organization; 1992.
19. Derogatis LR: The Symptom Checklist-90-revised Minneapolis: NCS
Assessments; 1992.
20. Derogatis LR: The Brief Symptom Inventory (BSI): Administration, scoring and
procedures manual. 3 edition. Mineapolis: National Computer System; 1993.
21. Beck AT, Steer RA: Beck Depression Inventory San Antonio: The Psychological
Corporation Inc.; 1987.
22. Forkmann T, Boecker M, Norra C, Eberle N, Kircher T, Schauerte P,
Mischke K, Westhofen M, Gauggel S, Wirtz M: Development of an item
bank for the assessment of depression in persons with mental illnesses
and physical diseases using Rasch analysis. Rehabil Psychol 2009,
54:186-197.
23. Hedges LV, Olkin I: Statistical Methods for Meta-Analysis Orlando: Academic
Press; 1985.
24. Cohen J: Statistical power for the behavioural science. 2 edition. Hillsdale:
Erlbaum; 1988.
25. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ: Meta-analysis of experiments
with matched groups or repeated measures designs. Psychol Methods
1996, 1:170-177.
26. Wittchen HU, Jacobi F: Size and burden of mental disorders in Europe- a
critical review and appraisal of 27 studies. Eur Neuropsychopharmacol
2005, 15:357-376.
27. Abramowitz JS: Treatment of obsessive-compulsive disorder in patients
who have comorbid major depression. J Clin Psychol 2004, 60:1133-1141.
28. DeVane CL, Chiao E, Franklin M, Kruep EJ: Anxiety disorders in the 21st
century: status, challenges, opportunities, and comorbidity with
depression. Am J Manag Care 2005, 11:S344-S353.
29. Rudisch B, Nemeroff CB: Epidemiology of comorbid coronary artery
disease and depression. Biol Psychiatry 2003, 54:227-240.
30. Robinson RG: Poststroke depression: prevalence, diagnosis, treatment,
and disease progression. Biol Psychiatry 2003, 54:376-387.
31. Stunkard AJ, Faith MS, Allison KC: Depression and obesity. Biol Psychiatry
2003, 54:330-337.
32. Raison CL, Miller AH: Depression in cancer: new developments regarding
diagnosis and treatment. Biol Psychiatry 2003, 54:283-294.
33. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM:
Prevalence, diagnosis, and pharmacological treatment of mood
disorders in HIV disease. Biol Psychiatry 2003, 54:307-316.
34. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H,
Fauerbach JA: Even minimal symptoms of depression increase mortality
risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
35. Norra C, Skobel EC, Arndt M, Schauerte P: High impact of depression in
heart failure: early diagnosis and treatment options. Int J Cardiol 2008,
125:220-231.
36. Forkmann T, Boecker M, Wirtz M, Eberle N, Westhofen M, Schauerte P,
Mischke K, Kircher T, Gauggel S, Norra C: Development and validation of
the Rasch-based depression screening (DESC) using Rasch analysis and
structural equation modelling. J Behav Ther Exp Psychiatry 2009, 40:468-78.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6815/11/7/prepub
doi:10.1186/1472-6815-11-7
Cite this article as: Forkmann et al.: Prevalence and psychopathological
characteristics of depression in consecutive otorhinolaryngologic
inpatients. BMC Ear, Nose and Throat Disorders 2011 11:7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Forkmann et al. BMC Ear, Nose and Throat Disorders 2011, 11:7
http://www.biomedcentral.com/1472-6815/11/7
Page 7 of 7
